MGDGs present both anti-inflammatory and anti-cancer activities while SQDGs present immunostimulatory activities and inhibit the enzyme glutaminyl cyclase, which is involved in Alzheimer’s disease. This evidence concerns the gene QPCT and early-onset autosomal dominant Alzheimer disease.